FDA 483 - Frank Dinenno - January 23, 2018

Frank Dinenno, a Sponsor-Investigator in Fort Collins, CO, was inspected by the FDA and cited for two observations related to inadequate record-keeping for investigational drugs. The firm failed to maintain complete disposition records for investigational products, preventing full reconciliation. Additionally, subject records lacked sufficient detail regarding treatment received in a specific study.